These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM. Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811 [Abstract] [Full Text] [Related]
3. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis. Knipscheer HC, Nurmohamed MT, Van den Ende A, Plaat B, Pruijs HJ, Mulder WJ, Kastelein JJ. J Intern Med; 1994 Oct 15; 236(4):377-84. PubMed ID: 7931040 [Abstract] [Full Text] [Related]
5. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome. de Zeeuw D, Gansevoort RT, Dullaart RP, de Jong PE. J Hypertens Suppl; 1995 Jul 15; 13(1):S53-8. PubMed ID: 18800457 [Abstract] [Full Text] [Related]
6. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil. Zhao SP, Smelt AH, Leuven JA, Vroom TF, van der Laarse A, van 't Hooft FM. Am J Med; 1994 Jan 15; 96(1):49-56. PubMed ID: 8304363 [Abstract] [Full Text] [Related]
12. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins. Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P. Can J Cardiol; 1991 Jan 15; 7(1):27-33. PubMed ID: 2025787 [Abstract] [Full Text] [Related]
13. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. Lamendola C, Abbasi F, Chu JW, Hutchinson H, Cain V, Leary E, McLaughlin T, Stein E, Reaven G. Am J Cardiol; 2005 Jan 15; 95(2):189-93. PubMed ID: 15642550 [Abstract] [Full Text] [Related]
17. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF. Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526 [Abstract] [Full Text] [Related]
18. Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Wiklund O, Angelin B, Bergman M, Berglund L, Bondjers G, Carlsson A, Lindén T, Miettinen T, Odman B, Olofsson SO. Am J Med; 1993 Jan 15; 94(1):13-20. PubMed ID: 8420296 [Abstract] [Full Text] [Related]
19. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results. Ros E, Zambón D, Bertomeu A, Cusó E, Sanllehy C, Casals E. Arch Intern Med; 1991 Feb 15; 151(2):301-5. PubMed ID: 1992957 [Abstract] [Full Text] [Related]
20. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I. Crepaldi G, Baggio G, Arca M, Avellone G, Avogaro P, Bittolo Bon G, Bompiani GD, Capurso A, Cattin L, D'Alŏ G. Arch Intern Med; 1991 Jan 15; 151(1):146-52. PubMed ID: 1898694 [Abstract] [Full Text] [Related] Page: [Next] [New Search]